LICENSE AGREEMENT WITH OYAGEN (Details Narrative) - USD ($) |
3 Months Ended | |
|---|---|---|
Apr. 14, 2021 |
Jun. 30, 2021 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Value of shares issued | $ 3,000,000 | |
| License Agreement [Member] | OyaGen Inc [Member] | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Number of shares issued (in shares) | 86,010 | |
| Value of shares issued | $ 3,000,000 |
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|